In cancer cells, YY1’s impact extends to the regulation of key anti-apoptotic genes, including Bcl-2, Bcl-xl, Mcl-1, and survivin, known for their involvement in therapeutic resistance and cancer progression. Here, BCL2L1 is linked to cancer.